Fineline Cube

Follow:
14436 Articles
Jiangxi Rimag Lists CT Chest Lesion Data on Shanghai Data Exchange
Company

Jiangxi Rimag Lists CT Chest Lesion Data on Shanghai Data Exchange

Novartis' Fabhalta Approved in China for C3 Glomerulopathy
CompanyDrug

Novartis’ Fabhalta Approved in China for C3 Glomerulopathy

Shionogi Submits Rolling NDA for Ensitrelvir in US for COVID-19 Prophylaxis
CompanyDrug

Shionogi Submits Rolling NDA for Ensitrelvir in US for COVID-19 Prophylaxis

China's National Health Commission Outlines Key Tasks for Primary Healthcare Reform in 2025
Policy / Regulatory

China’s National Health Commission Outlines Key Tasks for Primary Healthcare Reform in 2025

Pfizer Expands Abrysvo RSV Vaccine Indication to Include Ages 18-59 in EU
CompanyDrug

Pfizer Expands Abrysvo RSV Vaccine Indication to Include Ages 18-59 in EU

AccurEdit's ARTbase-A1 Base Editor Authorized by USPTO
CompanyDrug

AccurEdit’s ARTbase-A1 Base Editor Authorized by USPTO

Organon Acquires U.S. Rights to TOFIDENCE from Biogen
CompanyDeals

Organon Acquires U.S. Rights to TOFIDENCE from Biogen

Zhifei Bio's Trivalent Influenza Vaccine Approved for Clinical Trials in China
CompanyDrug

Zhifei Bio’s Trivalent Influenza Vaccine Approved for Clinical Trials in China

ChemPartner Plans Share Issuance to Raise Up to 316.3 Million Yuan
CompanyDeals

ChemPartner Plans Share Issuance to Raise Up to 316.3 Million Yuan

Peijia Medical and DSM-Firmenich Collaborate on Polymer Heart Valve Innovation
CompanyDeals

Peijia Medical and DSM-Firmenich Collaborate on Polymer Heart Valve Innovation

Henlius and Organon's HLX11 Biosimilar Clears EMA Validation Hurdle
CompanyDrug

Henlius and Organon’s HLX11 Biosimilar Clears EMA Validation Hurdle

Huadong Medicine's Semaglutide Injection Accepted for Review by China's NMPA
CompanyDrug

Huadong Medicine’s Semaglutide Injection Accepted for Review by China’s NMPA